World Journal of Surgical Oncology (Feb 2024)

C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer

  • Christian Lang,
  • Zsolt Megyesfalvi,
  • Andras Lantos,
  • Felicitas Oberndorfer,
  • Mir Alireza Hoda,
  • Anna Solta,
  • Bence Ferencz,
  • Janos Fillinger,
  • Anna Solyom-Tisza,
  • Alessandro Saeed Querner,
  • Felix Egger,
  • Kristiina Boettiger,
  • Thomas Klikovits,
  • Gerald Timelthaler,
  • Ferenc Renyi-Vamos,
  • Clemens Aigner,
  • Konrad Hoetzenecker,
  • Viktoria Laszlo,
  • Karin Schelch,
  • Balazs Dome

DOI
https://doi.org/10.1186/s12957-024-03315-7
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background By being highly involved in the tumor evolution and disease progression of small cell lung cancer (SCLC), Myc family members (C-Myc, L-Myc, and N-Myc) might represent promising targetable molecules. Our aim was to investigate the expression pattern and prognostic relevance of these oncogenic proteins in an international cohort of surgically resected SCLC tumors. Methods Clinicopathological data and surgically resected tissue specimens from 104 SCLC patients were collected from two collaborating European institutes. Tissue sections were stained by immunohistochemistry (IHC) for all three Myc family members and the recently introduced SCLC molecular subtype-markers (ASCL1, NEUROD1, POU2F3, and YAP1). Results IHC analysis showed C-Myc, L-Myc, and N-Myc positivity in 48%, 63%, and 9% of the specimens, respectively. N-Myc positivity significantly correlated with the POU2F3-defined molecular subtype (r = 0.6913, p = 0.0056). SCLC patients with C-Myc positive tumors exhibited significantly worse overall survival (OS) (20 vs. 44 months compared to those with C-Myc negative tumors, p = 0.0176). Ultimately, in a multivariate risk model adjusted for clinicopathological and treatment confounders, positive C-Myc expression was confirmed as an independent prognosticator of impaired OS (HR 1.811, CI 95% 1.054–3.113, p = 0.032). Conclusions Our study provides insights into the clinical aspects of Myc family members in surgically resected SCLC tumors. Notably, besides showing that positivity of Myc family members varies across the patients, we also reveal that C-Myc protein expression independently correlates with worse survival outcomes. Further studies are warranted to investigate the role of Myc family members as potential prognostic and predictive markers in this hard-to-treat disease.

Keywords